PGHH_AR_2020

REPORT OF THE DIRECTORS Annual Report 2019-20 5 Company Overview Board's Report MD&A Corporate Governance Financial Statements Procter & Gamble Hygiene and Health Care Limited Your Directors have the pleasure of presenting the 56 th Annual Report and the Audited Financial Statements of your Company for the Financial Year ended June 30, 2020. FINANCIAL RESULTS (Figures in ` crores) 2019-20 2018-19 Revenue from operations 3,002 2,947 Profit before tax (PBT) 594 607 Profit after tax (PAT) 433 419 FINANCIAL YEAR Your Company follows its Financial Year as July 1 st to June 30 th . DIVIDEND The Directors are pleased to recommend a final dividend of ` 105 per Equity Share for the Financial Year ended June 30, 2020. This dividend proposal is subject to approval of the Shareholders at the ensuing 56 th Annual General Meeting. BUSINESS PERFORMANCE Your Company delivered another year of resilient performance in tough external environment. During the Financial Year, business operations were disrupted across the country following the nation- wide lockdown imposed to contain the spread of COVID-19. In this unprecedented environment, your Company delivered a resilient performance for the Financial Year with sales of ` 3,002 crores, up 2% vs year ago and Profit After Tax (PAT) of ` 433 crores, up 3% vs year ago. Hygiene Business In the feminine care business, Whisper continues to hold its position as the market leader. We continue to delight the consumer with strong innovation across the portfolio. We strengthened our play in the emerging “Comfort & Soft” segment with the launch of Whisper Choice Aloe Vera longer length while also upgrading our flagship Ultra and Choice portfolio to significantly improve consumer experience. We also launched Whisper #KeepGirlsInSchool campaign, to raise awareness about the issue of girls dropping out of school when they attain puberty and how to address the same. Whisper continues to bring transformational change in the community. Through our Whisper School program, last year we actively supported 40,000 schools educating about 50 lakh adolescent girls on the importance of menstrual hygiene. Our campaign 'Meri Life Mere Rules' drove significant social media conversation on breaking societal limitations for girls. We continued to drive penetration of our portfolio via sharply defined go-to-market plans. Health Care Business Your Company’s health care sales posted strong growth this Financial Year, despite external challenges due to COVID-19. Your Company continued to win externally and grow share in the Cough & Cold category with strong offtake growth behind the strength of our portfolio, which includes Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler andVicks BabyRub . The growth was driven by strong innovation with launch of Vicks 3-in-1 throat lozenges, strong demand creation with world-class communication across all our sub-brands to continue growing our share, along with superior go-to-market, which enabled our brands to be present in many more stores than our competition.